Species differences in hepatocyte induction of CYP1A1 and CYP1A2 by omeprazole

Human and Experimental Toxicology

Volumn 18, Issue 2, 1999, Pages 95-105

  Shih, Hsueh ^a   Pickwell, George V ^a   Guenette, Denis K ^a   Bilir, Bahri ^a   Quattrochi, Linda C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

CYP1A; Hepatocytes; Human; Omeprazole

Indexed keywords

CYTOCHROME P450; MESSENGER RNA; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; HUMAN; HUMAN CELL; LIVER CELL CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SPECIES DIFFERENCE; TIME;

ANIMALS; ANTI-ULCER AGENTS; BLOTTING, NORTHERN; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; HUMANS; LIVER; MALE; MICE; OMEPRAZOLE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ARYL HYDROCARBON; SPECIES SPECIFICITY; TIME FACTORS;

EID: 0032986552     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/096032799678839699     Document Type: Article

References (46)

1. Howden CW. Clinical pharmacology of omeprazole. Clinical Pharmacokinetics 1991; 20: 38-49.
2. Diaz D et al. Omeprazole is an aryl hydrocarbon-like inducer of human hepatic Cytochrome P450. Gastroenterology 1990; 99: 737-747.
3. McDonnell WM, Scheiman JM, Traber PG. Induction of cytochrome P450IA genes (CYP1A) by omeprazole in the human alimentary tract. Gastroenterology 1992; 103: 1509-1516.
4. Rost KL et al. Increase of cytochrome P450IA2 activity by omeprazole: Evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin. Clinical Pharmacological Therapeutics 1992; 52: 170-180.
5. Gonzalez FJ. Molecular genetics of the P-450 superfamily. Pharmacological Therapeutics 1990; 45: 1-38.
6. Liem HH, Muller-Eberhard U, Johnson EF. Differential induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin of multiple forms of rabbit microsomal cytochrome P-450: Evidence for tissue specificity. Molecular Pharmacology 1980; 18: 565-570.
7. 3450 genes: Differential transcriptional activation and mRNA stability in liver and extrahepatic tissues. Molecular and Cellular Biology 1986; 6: 1471-1477.
8. Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proceedings of the National Academy of Sciences, USA 1989; 86: 7696-7700.
9. McManus ME et al. Metabolism of 2-acetylamino-fluorene, benzo[a]pyrene and the activation of food derived heterocylic amine mutagens by human cytochromes P450. Cancer Research 1990; 50: 3367-3376.
10. Crespi CL et al. The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3. Carcinogenesis 1991; 12: 355-359.
11. Denison MS, Whitlock JP Jr. Xenobiotic-inducible transcription of cytochrome P450 genes. Journal of Biological Chemistry 1995; 270: 18175-18178.
12. Quattrochi LC, Tukey RH. Nuclear uptake of the Ah (Dioxin) receptor in response to omeprazole: Transcriptional activation of the human CYP1A1 gene. Molecular Pharmacology 1993; 43: 504-508.
13. Lesca P et al. Evidence for the ligand-independent activation of the Ah receptor. Biochimica et Biophysica Acta 1995; 209: 474-482.
14. Aix L et al. Thiabendazole is an inducer of cytochrome P4501A1 in cultured rabbit hepatocytes. Biochimica et Biophysica Acta 1994; 202: 1483-1489.
15. Curi-Pedrosa R et al. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human heptocytes in primary culture. Journal of Pharmacology and Experimental Therapeutics 1994; 269: 384-392.
16. Kashfi K, McDougall CJ, Dannenberg AJ. Comparative effects of omeprazole on xenobiotic metabolizing enzymes in the rat and human. Clinical Pharmacological Therapeutics 1995; 58: 625-630.
17. Backlund M, Johansson I, Mkrtchian S, Ingelman-Sundberg M. Signal Transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cells. Journal of Biological Chemistry 1997; 272: 31755-31763.
18. Masubuchi N, Okazaki O. An evaluation of the CYP1A induction potential of pantoprazole in primary rat hepatocytes: a comparison with other proton pump inhibitors. Chemico-Biological Interactions 1997; 107: 63-74.
19. Kikuchi H et al. Different Inducibility of cytochrome P-4501A1 mRNA of human and mouse by omeprazole in culture cells. Archives of Biochemistry and Biophysics 1995; 316: 649-652.
20. Dzeletovic N et al. Regulation of dioxin receptor function by omeprazole. Journal of Biological Chemistry 1997; 272: 12705-12713.
21. Li D, Schuetz EG. Guzelian PS. Hepatocyte culture in study of P450 regulation. Methods in Enzymology 1991; 206: 335-344.
22. Kocarek TA et al. Comparative analysis of P450 3A induction in primary cultures of rat, rabbit and human hepatocytes. Drug Metabolism and Disposition 1994; 23: 415-421.
23. Pasco DS et al. Transcriptional and post-transcriptional regulation of the genes encoding cytochromes P-450c and P-450d in vivo and in primary hepatocyte cultures. Journal of Biological Chemistry 1988; 263: 8671-8676.
24. Silver G, Reid LM, Krauter KS. Dexamethasone-mediated regulation of 3-methylcholanthrene-induced cytochrome P-450d mRNA accumulation in primary rat hepatocyte cultures. Journal of Biological Chemistry 1990; 265: 3134-3138.
25. Kleinman HK et al. Basement membrane complexes with biological activity. Biochemistry 1985; 25: 312-318.
26. Selgen PO. Preparation of isolated rat liver cells. Methods in Cell Biology 1976; 13: 29-83.
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1987; 162: 156-159.
28. Quattrochi LC, Okino ST, Pendurthi UR, Tukey RH. Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding p-450 4 and P-450 6. DNA 1985; 4: 395-400.
29. Quattrochi LC et al. Human cytochrome P-450 4 mRNA and gene: Part of a multigene family that contains Alu sequences in its mRNA. Proceedings of the National Academy of Sciences, USA 1986; 83: 6731-6735.
30. Okino ST et al. Cloning and characterization of cDNAs encoding 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible rabbit mRNAs for cytochrome P-450 isozymes 4 and 6. Proceedings of the National Academy of Sciences, USA 1985; 82: 5310-5314.
31. Okino ST, Pendurthi UR, Tukey RH. Phorbol esters inhibit the dioxin receptor mediated transcriptional activation of the mouse Cyp1A1 and Cyp1A2 genes by TCDD. Journal of Biological Chemistry 1992; 267: 6991-6998.
32. Gunning P et al. Isolation and characterization of full-length cDNA clones for human α-, β-and gamma-actin mRNAs: Skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Molecular and Cellular Biology 1983; 3: 787-795.
33. Daujat M et al. Omeprazole, an inducer of human CYP1A1 and CYP1A2, is not a ligand for the Ah receptor. Biochimica et Biophysica Acta 1992; 188: 820-825.
34. Daujat M et al. Induction of CYP1A1 gene by benzimidazole derivatives during Caco-2 cell differentiation. Evidence for an aryl-hydrocarbon receptor-mediated mechanism. European Journal of Biochemistry 1996; 237: 642-652.
35. Kocarek TA, Schuetz EG, Guzelian PS. Transient induction of cytochrome P450 1A1 mRNA by culture medium component in primary cultures of adult rat hepatocytes. In Vitro Cellular and Developmental Biology 1993; 29A: 62-66.
36. Quattrochi LC, Vu T, Tukey RH. The human CYP1A2 gene and induction by 3-methylcholanthrene: A region of DNA that supports Ah-receptor binding and promoter-specific induction. Journal of Biological Chemistry 1994; 269: 6949-6954.
37. Fernandez-Salguero P et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995; 268: 722-726.
38. Rey-Grobellet X et al. Structural requirements for the induction of cytochromcs P450 by benzimidazole anthelmintic derivatives in cultured rabbit hepatocytes. Biochemical Biophysical Research Communications 1996; 220: 789-794.
39. Rost KL, Brosicke H, Heinemeyer G, Roots I. Specific and dose-dependent enzyme induction by omeprazole in human beings. Hepatology 1994; 20: 1204-1212.
40. Rost KL, Roots I. Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: Coincidence with plasma clearance and breath test. Clinical Pharmacological Therapeutics 1994; 55: 402-411.
41. Nousbaum JB et al. Four-week treatment with omeprazole increases the metabolism of caffeine. American Journal of Gastroenterology 1994; 89: 371-375.
42. Rizzo N et al. Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions. European Journal of Clinical Pharmacology 1996; 49: 491-495.
43. Andersson T et al. Omeprazole treatment does not affect the metabolism of caffeine. Gastroenterology 1991; 101: 943-947.
44. Buchthal J et al. Induction of cytochrome P4501A by smoking or omeprazole in comparison with UDP-glucuronosyltransferase in biopsies of human duodenal mucosa. European Journal of Clinical Pharmacology 1995; 47: 431-435.
45. Nebert DW, Peterson DD, Puga A. Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin. Pharmacogenetics 1991; 1: 68-78.
46. Garrison PM et al. Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. Fundamental and Applied Toxicology 1996; 30: 194-203.